Defibrillation testing during implantation of the subcutaneous implantable cardioverter-defibrillator: a necessary standard or becoming redundant?

Since the publication of the SIMPLE and NORDIC trials, defibrillation testing (DFT) is rarely performed during routine implantation of transvenous implantable cardioverter-defibrillators (ICD). However, the results of these trials cannot be extrapolated to the later introduced subcutaneous ICD (S-IC...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Stuijt, W., Quast, A. B. E., Knops, R. E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bohn Stafleu van Loghum 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7419406/
https://www.ncbi.nlm.nih.gov/pubmed/32780342
http://dx.doi.org/10.1007/s12471-020-01448-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7419406/
https://www.ncbi.nlm.nih.gov/pubmed/32780342
http://dx.doi.org/10.1007/s12471-020-01448-4

Ejemplares similares